The Team

Principal investigators

Jennifer Moodley is a public health medicine physician and Director of the Cancer Research Initiative in the Faculty of Health Sciences, University of Cape Town. She has extensive experience in health systems research, epidemiology and public policy development. Jennifer has first-hand experience of the challenges experienced in providing health care in resource-constrained environments.

Fiona Walter is a primary care doctor (specialist family physician) and leads the Primary Care Cancer Research group at the University of Cambridge’s Department of Public Health and Primary Care. Her research focuses on timely detection and diagnosis of cancer. She co-leads the Cancer Research UK-funded international CanTest Collaborative, spearheading new approaches to cancer diagnostics, and developing training opportunities for future leaders of community-based cancer research.

Research team

• Suzanne E Scott, Kings College London
• Amos D Mwaka, University of Makerere
• Deborah Constant, University of Cape Town
• Jennifer Githaiga, University of Cape Town
• Jane Harries, University of Cape Town
• Lydia Cairncross, University of Cape Town and Groote Schuur Hospital
• Nontuthuzelo IM Somdyala, Sount African Medical Research Council
• Henry Wabinga, University of Makerere
• Edina Sinanovic, University of Cape Town
• Chukwudi Nnaji, University of Cape Town
• Jennifer Langoya, University of Makerere
• Rosemary Jacobs, UMTHA consultancy
• Fikile Mbuzi, St Elizabeth’s Hospital

 Students

• Tessa S Stewart, Universty of Cambridge
• Trish Muzenda, University of Cape Town
• Amanda Edwards, University of Cape Town
• Alexandra Payne, University of Cape Town
• Christabel Abewe, University of Cape Town
• Jackie Lalam, University of Makerere
• Adoch Winnie, University of Makerere
• Ocira Denis, University of Makerere
• Acan Jennifer, University of Makerere

Funders

This work has been funded by the Cancer Association of South Africa; the University of Cape Town, and the South African Medical Research Council with funds received from the South African  National Department of Health, GlaxoSmithKline Africa Non-Communicable Disease Open Lab (via a supporting grant Project Number: 023), and with funds from the UK Government’s Newton fund.